Ueki, Yushi <br/><br/>
Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score.  [electronic resource] 

 -  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery  Aug 2020 
 - 2341-2347 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1434-4726 
<br/><br/><label>Standard No.: </label>10.1007/s00405-020-05945-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Nivolumab<br/>Prognosis<br/>Retrospective Studies<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy<br/>Treatment Outcome